Deck
Fiserv is a US payments and financial-technology processor that runs card acceptance, bank core account processing, and small-business point-of-sale (Clover), earning mostly recurring transaction and account fees under multi-year contracts.
The reset multiple looks cheap; the cash yield behind it is softer than it reads.
Fiserv's ~16% equity free-cash-flow yield rests on a $4,435M FCF figure that covered only 93% of adjusted net income in 2025 (down from 102% in 2024), falls to a full-cost ~$3.5-4.0B once the $780M of 2025 capital spending routed off the capex line is charged, and gets no relief from tax because cash income taxes of $1,369M already run ~32% of pretax income against a 19.0% book rate. At the normalized figure the equity yield eases to ~13-14%; 93% conversion is still healthy in absolute terms, and the durable haircut may be nearer the $345M of finance-lease principal actually paid than the full $780M.
The reset reaches Fiserv's deepest, highest-margin moat, not just Argentina and Clover.
- The inversion: the stickiest, highest-margin franchise — core bank processing inside Financial Solutions — is the half now shrinking, while the growth sits in Merchant and Clover, where switching costs are lowest and competition is hottest.
- Why the location matters: Financial Solutions is ~46% of revenue ($9.66B of $21.19B) and ~55% of segment operating profit at a 45.3% margin, so an eight-point organic swing lands in the most valuable half of the company.
- The other side: the DNA core still posts the industry's top independent satisfaction score (4.03 of 5), wins marquee mandates like the $7B Republic Bank, and Finxact grew 80% to 30M accounts — elevated attrition, not yet a broken moat.
The growth that set the valuation was substantially borrowed from Argentina.
Before: Fiserv reported organic revenue growth in the low double digits — 12% in 2023, 16% in 2024 — a pace that earned a premium multiple against slower-growing processing peers.
The reveal: stripped of Argentine hyperinflation, which ran 211% in 2023 and 118% in 2024, underlying organic growth was closer to 6% in both years; as inflation normalized toward 22%, the tailwind reversed and Q3 2025 organic growth fell to 1%.
After: the shares dropped about 44% in a single October 2025 session, and the merchant engine reset in step — Clover product-revenue growth stepped down from ~30% toward low-double-digits on a same-store base management now puts at about -3%.
Adjusted EPS sits 36% above GAAP, mostly on an amortization add-back.
Most of the GAAP-to-adjusted gap is the add-back of First Data acquisition-intangible amortization — a legitimate, declining non-cash charge, though serial acquisitions keep partly replenishing it. Less clean: rising capitalized-software amortization ($757M) stays inside adjusted earnings, and recurring "one-time" merger, severance, and transformation costs lean the adjustments toward the higher number. A 6x multiple is a multiple of that adjusted figure.
Capital returns ran ahead of cash, and the buyback bought high.
- Procyclical timing: Fiserv spent about $16B on repurchases in 2023-2025 at an average near $150 a share, retiring roughly a fifth of the count — then throttled to ~3.3M shares at ~$61 in early 2026, near the lows.
- Outspending cash: 2025 deployment of ~$7.1B on buybacks, M&A and minority interests outran $4.3B of free cash flow, leaving net debt ~$28B and leverage at the top of the 2.5-3.0x target.
- Rising charge: interest expense climbed 25% to ~$1.49B — about 26% of operating income — a durable cost that works directly against the free cash flow the equity is a levered claim on.
Three CEOs in thirteen months, and an unreserved legal overhang on the same cash.
- Leadership churn: three chief executives in about thirteen months — Bisignano left to run a federal agency in 2025, Lyons departed after roughly a year, and Georgakopoulos was appointed in June 2026.
- Litigation cluster: securities class actions over the Clover growth and 2025 guidance name former executives, alongside SEC and U.S. Attorney investigations into that guidance.
- Unreserved: the company says it cannot yet estimate the liability, so $0 is reserved — an unquantified potential draw on the same ~$4B of free cash flow the reset case depends on.
The case is most sensitive to whether the cash and earnings base stops falling — not to the multiple.
- The bargain case: ~6x adjusted earnings and a wide discount to peer FIS on a recurring-revenue base that converts ~90% of earnings to cash; management guides $12+ adjusted EPS and $13.5B+ cumulative free cash flow across 2027-2029.
- The trap case: adjusted EPS is guided down two years running on 1-3% organic growth, the high-margin core is shrinking, and interest, cash tax, and capital intensity all rise into a levered ~$28B-net-debt balance sheet.
- What decides it: free cash flow holding above ~$4B matters more than the growth rate — a levered equity re-rates on stabilization and compresses on a second leg down.
Watchlist to re-rate: Banking organic growth and core account counts turning back up (from -6% and -2%); free cash flow holding above ~$4B once off-statement capex and cash taxes are charged; and leverage trending toward the low end of 2.5-3.0x, with the securities and SEC/U.S. Attorney matters resolved rather than reserved.